Neurology® Podcast18 Aug 2014

August 19 2014 Issue

1) A clinical pathologic study of depressive symptoms and cognitive decline in old age and 2) Topic of the month: Contemporary alternative medicine therapies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Robert S. Wilson about his paper on depressive symptoms and cognitive decline in old age. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Rebecca Wells interviews Dr. Tieraona Low Dog about complementary alternative medicine therapies using supplements for treatment of headaches. The participants had nothing to disclose except Drs. Burns, Wilson and Numis. Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International and receives research support from the NIH, Alzheimer's Drug Discovery Foundation, Elan, Janssen Pharmaceuticals Inc., Wyeth, Pfizer Inc, Novartis Pharmaceuticals Ltd, Danone, Avid Radiopharmaceuticals, Merck Serono and for clinical trials. Dr. Wilson serves as a Consulting Editor of Aging, Neuropsychology and Cognition, Psychology and Aging, and Neuropsychology; is a consultant for Pain Therapeutics, Inc.; and receives research support from the NIH. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1371)

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was ...

27 Jul 26min

2026 International Conference on Functional Neurological Disorder

Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's...

23 Jul 24min

Exploring Military Sexual Trauma and Migraine Among US Veterans

Dr. Stacey Clardy talks with Dr. John Ney about the link between military sexual trauma and migraine among US veterans. Read the related article in Neurology® Clinical Practice. Disclosures can be f...

20 Jul 22min

Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants

Dr. Derek Stitt talks with Dr. Jennifer Morganroth about the evolving landscape of genetic testing in ALS, the importance of longitudinal care for at-risk individuals, and the capacity challenges face...

16 Jul 14min

When Drug Marketing Masquerades as Clinical Trials

Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Read the relat...

13 Jul 17min

Neurology® at 75: The Evolution of the Neurology Journal

To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®. Read more about the first ...

9 Jul 30min

Navigating the Transition From Pediatric to Adult Epilepsy Care

Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care. Read the related article in Neurology® Clinical Practice. Disclosures can be found a...

6 Jul 22min

Communication About Uncertainty During PD Diagnostic Consultations

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding. Read the rel...

2 Jul 16min